Latest: FDA Approves New Biosimilar for Oncology Treatment

Leveraging Networks to Deliver Novel Therapies to Community Populations

0 Mins
The expertise of START's network may streamline the availability of clinical trial enrollment and novel treatment options among patients with cancer.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago